Articles tagged with “loss-of-exclusivity”

Drug Patent Expirations 2027-2030: Market Entry Calendar

A dated calendar of drug patent, exclusivity, and settlement-based market-entry events for 2027-2030, with a reproducible method and September 2026 sourcing.

25 min read

9/5/2026

drug patent expirations patent cliff 2027 biosimilar market entry generic drug launch calendar pharma patent cliff 2030 biologics exclusivity orange book purple book loss of exclusivity pharmaceutical patents

2027 Drug Patent Expirations: LOE Calendar & Pipeline

Analyze 2027 drug patent expirations and the impending patent cliff. Review a detailed loss-of-exclusivity (LOE) calendar for biologics and small molecules.

25 min read

4/30/2026

drug patent expirations loss of exclusivity 2027 patent cliff loe calendar biosimilars generic drugs pharma pipeline biologics

Patent Cliff Strategy: Role of Competitive Intelligence Software

Learn how pharma firms use competitive intelligence software to mitigate patent cliff risks. Updated April 2026 with the Humira/CVS Caremark biosimilar shift, Stelara LOE, and AI-native CI platforms.

35 min read

1/9/2026

competitive intelligence patent cliff loss of exclusivity pharma strategy ci software biosimilar competition drug patent expiration lifecycle management